NCT03076437 2021-03-19Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell MalignanciesShenzhen Institute for Innovation and Translational MedicinePhase 1/2 Completed28 enrolled